Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Clinical trials targeting IL-22 in AD.
| Target Molecule | Clin Trial Gov | Type of Study | Status |
|---|---|---|---|
| IL-22 | |||
| Anti-IL-22 antibody Fezakinumab (ILV-094) |
NCT01941537 | Phase II | Completed |
| IL-22R1 | |||
| Anti-IL-22R1 antibody LEO 138559 |
NCT04922021 | Phase II for AD | Active, not recruiting |
| Anti-IL-22R1 antibody LEO 138559 |
NCT03514511 | Phase I | Completed |
| Anti-IL-22R1 antibody LEO 138559 |
NCT05099133 | Phase I | Completed |
| Anti-IL-22R1 antibody LEO 138559 |
NCT05470114 | Phase II | Recruiting |
